Best Practices, LLC has completed a multitude of research initiatives around pharmaceutical product development, launch, brand management and product lifecycle management. We have developed an expertise especially around the following areas:
Over the years, Best Practices, LLC has developed expertise across a broad spectrum of alliances and partnerships topics. Specific research areas include:
- Pharmaceutical Launches: Building Blockbusters
- Thought Leader Relationship Management
- Speaker Training
- Clinical Trial Management: Conducting Trials & Communicating Results
- Pharmaceutical Product Re-Launch
- Early-Stage Product Commercialization
- Brand Management & Marketing
- Pharmaceutical Alliances & Co-Promotions
- Drug Delivery Systems
- Pharmaceutical Sales Force Management
- Specialty Drug Marketing
- R&D Quality
This research study provided benchmark data on how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities.
Best Practices, LLC performed an industry-wide benchmark study on multi-phased marketing support for new products across an elite group of high performing pharmaceutical companies. The study includes 16 Blockbuster Product Case Studies and delivers benchmark data on:
- Developing and Deploying Integrated Marketing Support
- Investing for Maximum Impact
- Managing Team Structure, Communication & Transition
- Driving Commercially Focused Drug Development
- Preparing Market for Rapid Product Uptake
- Optimizing Commercial Resources for Launch Success
- Leading and Lagging Indicators for Brand Performance, Marketing Metrics Responsibilities, and Timeline and Competencies
- Marketing Publications Staffing
Product Re-launch - it is the hobgoblin of the pharmaceutical and biotech sector. Few brand leaders ever aspire to this marketing challenge. Yet many find they and their companies must confront re-launch scenarios – or sacrifice hundreds of millions of dollars invested in underperforming products.
A past research initiative probed best practices and lessons learned in successful product re-launches. The study also included two highly successful re-launch case studies: the history and lessons learned from Zithromax and Wellbutrin – two blockbuster products that nearly failed in the marketplace during their initial launches. With interviews and extensive survey data drawn from executives at leading pharmaceutical and biotech companies, our research serves as a guide to achieve an excellent product re-launch.
Whether you are looking for ways to improve the brand and lifecycle management of your portfolio or are facing a re-launch of a product that has not achieved its potential upon initial market entry, our team is ready to assist you by identifying the best re-launch practices from the marketing and brand leaders that have directed their re-launched products to blockbuster success.
Specialty pharmaceutical product marketers strive to effectively allocate their resources among various marketing activities and budget categories. Top executives who are marketing specialty products report that detailing, professional relations and market research have the best levels of ROI.
Past research in this area has benchmarked budget allocation, top pre- and post-launch activities, and primary target audiences. Whether you are trying to expand the market or achieve greater market share, Best Practices, LLC can assist you in determining the best pre- and post-launch strategy for your specialty product.
Pharmaceutical companies spend considerable resources conducting large clinical studies to support the launch of new products or expand indications for currently marketed products. Pharmaceutical companies that can leverage that investment by linking the benefits shown in clinical trials to key products will gain significant advantage in the market.
Best Practices, LLC can help your organization benchmark best-in-class companies and uncover the best strategies and tactics for maximizing the impact of clinical trial results.